John Murphy, M.D., M.P.H., D.P.H. President COVID-19 Long-haul Foundation
Abstract
Long COVID, also termed post-COVID condition or post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as one of the most significant chronic disease burdens of the twenty-first century. Among the diverse pathophysiologic mechanisms proposed to underlie persistent symptoms, vascular injury has become increasingly recognized as a central biological process. Studies published during 2026 have further strengthened evidence implicating endothelial dysfunction, immunothrombosis, microvascular inflammation, impaired nitric oxide signaling, endothelial senescence, and persistent immune activation as contributors to the clinical manifestations of long COVID.
Recent investigations suggest that vascular pathology extends beyond residual injury from acute infection and may represent a self-sustaining disease process driven by persistent inflammatory signaling, aberrant coagulation pathways, viral antigen persistence, and dysregulated endothelial repair. Emerging genomic and metabolomic studies have identified signatures consistent with chronic endothelial stress, mitochondrial dysfunction, altered cellular energy metabolism, and sustained activation of inflammatory cascades.
This review synthesizes peer-reviewed evidence published during 2026 concerning the etiology, genomics, pathology, physiology, clinical manifestations, disease progression, therapeutic management, and long-term prognosis of vascular injury associated with long COVID.
Introduction
The recognition of long COVID transformed understanding of SARS-CoV-2 infection from an acute respiratory illness into a multisystem disease capable of producing prolonged morbidity. While pulmonary, neurologic, autonomic, and immunologic manifestations remain prominent, mounting evidence suggests that vascular pathology may represent a common denominator linking diverse symptom clusters. Persistent fatigue, exertional intolerance, cognitive dysfunction, orthostatic symptoms, chest pain, dyspnea, and exercise intolerance can all be interpreted through the lens of impaired tissue perfusion and endothelial dysfunction.
The vascular endothelium serves as a dynamic endocrine and immunologic organ regulating vasodilation, coagulation, inflammatory signaling, leukocyte trafficking, and tissue repair. SARS-CoV-2 infection has demonstrated a unique capacity to disrupt endothelial homeostasis through direct and indirect mechanisms.
Recent studies published in 2026 have expanded understanding of how endothelial injury may persist long after resolution of acute infection and may contribute to chronic disease states resembling other post-viral syndromes including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Etiology of Vascular Injury in Long COVID
Endothelial Dysfunction
The most consistently reported vascular abnormality in long COVID is endothelial dysfunction.
Evidence accumulated during 2026 indicates persistent impairment of endothelial-mediated vasodilation, altered nitric oxide bioavailability, increased oxidative stress, and chronic inflammatory activation. These abnormalities appear capable of reducing blood flow regulation throughout multiple organ systems.
Several mechanisms have been proposed:
- Residual endothelial injury from acute infection
- Persistent inflammatory cytokine signaling
- Autoimmune activation
- Viral antigen persistence
- Oxidative stress
- Mitochondrial dysfunction
- Impaired endothelial regeneration
Endothelial Senescence
One of the most influential mechanistic publications of 2026 proposed endothelial senescence as a central driver of long COVID pathology. According to this model, acute viral infection induces endothelial cells to enter a senescent state characterized by chronic inflammatory signaling, impaired repair capacity, vasoconstrictive tendencies, procoagulant behavior, and altered tissue homeostasis.
Senescent endothelial cells produce a senescence-associated secretory phenotype (SASP) that promotes:
- Chronic inflammation
- Oxidative stress
- Coagulation activation
- Tissue fibrosis
- Impaired angiogenesis
The authors propose that failure of immune-mediated clearance of senescent endothelial cells may contribute to disease persistence.
Persistent Immunothrombosis
A second major etiologic hypothesis involves persistent immunothrombosis.
Systematic reviews published in 2026 identified ongoing platelet activation, fibrin abnormalities, complement activation, and impaired fibrinolysis as recurring findings among long COVID cohorts.
These abnormalities may produce:
- Microvascular obstruction
- Tissue hypoperfusion
- End-organ dysfunction
- Exertional intolerance
The concept of persistent microclot formation continues to attract substantial scientific interest, although standardization of measurement techniques remains incomplete.
Genomic and Molecular Findings
Transcriptomic Alterations
Emerging molecular studies indicate persistent activation of inflammatory transcriptional programs.
Reported pathways include:
- Interferon signaling
- IL-6 signaling
- JAK-STAT activation
- Complement pathways
- Oxidative stress pathways
These findings support the hypothesis that long COVID may represent a chronic inflammatory state rather than merely residual tissue damage.
Metabolomic Evidence
A major metabolomic investigation published in 2026 identified widespread bioenergetic disruption among long COVID patients. The study demonstrated abnormalities involving mitochondrial energy metabolism and pathways related to oxidative stress and cellular respiration.
These findings are potentially relevant to vascular pathology because endothelial cells are highly dependent upon tightly regulated metabolic signaling.
Pathology
Microvascular Injury
Pathologic evidence increasingly supports diffuse microvascular involvement.
Observed abnormalities include:
- Endothelial activation
- Platelet aggregation
- Microthrombi
- Complement deposition
- Capillary rarefaction
- Vascular remodeling
These processes may impair oxygen delivery even in the absence of major vessel disease.
Nitric Oxide Dysregulation
A 2026 cardiovascular investigation demonstrated abnormalities in the ADMA-DDAH-NOx pathway among patients with cardiovascular manifestations of long COVID. The findings suggest reduced nitric oxide bioavailability and impaired endothelial function.
Nitric oxide is essential for:
- Vasodilation
- Platelet regulation
- Vascular repair
- Microcirculatory blood flow
Disruption of nitric oxide signaling may therefore contribute to fatigue, exercise intolerance, and autonomic dysfunction.
Physiologic Consequences
Impaired Tissue Perfusion
A unifying physiologic consequence of vascular injury is impaired tissue perfusion.
Potentially affected systems include:
- Brain
- Heart
- Skeletal muscle
- Kidneys
- Gastrointestinal tract
Reduced regional blood flow may explain many symptoms despite normal conventional imaging findings.
Exercise Intolerance
Exercise intolerance remains among the most prevalent manifestations of long COVID.
Recent evidence demonstrates measurable endothelial abnormalities before and after exercise testing. A 2026 study reported that submaximal exercise acutely improved endothelial function among long COVID patients, suggesting persistent but potentially reversible endothelial impairment.
Clinical Manifestations
Common vascular-associated symptoms include:
- Fatigue
- Post-exertional symptom exacerbation
- Dyspnea
- Chest discomfort
- Palpitations
- Orthostatic intolerance
- Cognitive dysfunction
- Headaches
- Exercise intolerance
These symptoms frequently fluctuate and may worsen following physical or cognitive exertion.
Clinical Progression
Longitudinal studies continue to reveal marked heterogeneity.
Observed trajectories include:
Recovery Phenotype
Gradual improvement over months to years.
Persistent Phenotype
Stable symptom burden with limited spontaneous resolution.
Relapsing Phenotype
Periods of improvement interrupted by exacerbations.
Refractory Phenotype
Persistent severe disability.
Large-scale phenotype analyses conducted in 2026 support the existence of multiple biologically distinct subgroups.
Therapeutic Management
Exercise Rehabilitation
Exercise remains controversial.
Some patients benefit from carefully supervised rehabilitation, while others experience worsening symptoms.
Emerging evidence suggests endothelial function may improve acutely following submaximal exercise testing, although this finding does not establish universal benefit.
Antithrombotic Approaches
Interest continues regarding:
- Antiplatelet therapies
- Anticoagulants
- Fibrinolytic interventions
However, evidence remains insufficient for routine recommendation outside established clinical indications. A 2026 network meta-analysis identified potential reductions in thrombotic events with anticoagulant strategies but also increased bleeding risk.
Endothelial-Targeted Therapies
Potential future strategies include:
- Nitric oxide modulation
- Endothelial repair therapies
- Anti-inflammatory approaches
- Senolytic therapies
- Mitochondrial-directed treatments
At present, robust randomized evidence remains limited.
Long-Term Prognosis
Long-term prognosis remains uncertain.
Several observations are supported by current evidence:
- Many patients improve gradually over time.
- A substantial subset remains symptomatic for years.
- Persistent endothelial dysfunction may contribute to prolonged morbidity.
- The relationship between long COVID and future cardiovascular risk remains under active investigation.
Current evidence does not establish inevitable progression toward major cardiovascular disease, but neither does it exclude that possibility.
Conclusions
Research published during 2026 has substantially strengthened the vascular paradigm of long COVID. Endothelial dysfunction, endothelial senescence, immunothrombosis, nitric oxide dysregulation, chronic inflammation, and impaired microvascular perfusion have emerged as interconnected mechanisms capable of explaining many clinical manifestations of the disease.
Although significant uncertainties remain, the convergence of molecular, physiologic, metabolomic, and clinical evidence increasingly supports the hypothesis that vascular pathology represents a major component of long COVID pathogenesis. Future investigations will need to determine whether these abnormalities represent persistent consequences of acute infection, manifestations of ongoing viral antigen exposure, autoimmune phenomena, or a combination of these processes.
Large prospective studies, standardized biomarker programs, and randomized therapeutic trials remain essential to define causality and identify effective interventions.
References
- Nunes M, et al. Cell Death & Disease. 2026. Endothelial senescence and long COVID.
- Stojanovic M, et al. International Journal of Molecular Sciences. 2026. Vascular complications of long COVID.
- García-Hidalgo MC, et al. Journal of Translational Medicine. 2026. Metabolomic disruption in long COVID.
- Rakab MSS, et al. Frontiers in Cardiovascular Medicine. 2026. ADMA-DDAH-NOx pathway dysregulation.
- Santos-de-Araújo AD, et al. Scientific Reports. 2026. Endothelial function and exercise testing in long COVID.
- Perego E. COVID. 2026. Overview and pathophysiology of long COVID.